Bioteque Corporation
Taipei ExchangeTotal Valuation
Bioteque Corporation carries a market capitalization of 8.14B, placing it among publicly traded companies globally. Its enterprise value stands at 7.29B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.14B |
| Enterprise Value | 7.29B |
Share Statistics
Bioteque Corporation currently has 69.30M shares outstanding.
| Shares Outstanding | 69.30M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Bioteque Corporation trades at a trailing price-to-earnings ratio of 15.50. The price-to-sales ratio is 3.91, and the price-to-book ratio stands at 3.14.
| PE Ratio | 15.50 |
| PS Ratio | 3.91 |
| PB Ratio | 3.14 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | 11.60 |
| P/OCF Ratio | 12.58 |
Enterprise Valuation
On an enterprise value basis, Bioteque Corporation trades at an EV/EBITDA multiple of 10.87 and an EV/FCF ratio of 10.01. The EV/Sales ratio of 3.41 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.87 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.41 |
| EV / EBITDA | 10.87 |
| EV / EBIT | 10.87 |
| EV / FCF | 10.01 |
Financial Position
Bioteque Corporation maintains a current ratio of 4.27, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.56, indicating elevated leverage, while an interest coverage ratio of 88.88 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.27 |
| Quick Ratio | 3.05 |
| Debt / Equity | 16.56 |
| Debt / EBITDA | 0.89 |
| Interest Coverage | 88.88 |
Financial Efficiency
Bioteque Corporation posts a return on equity of 20.80 and a return on invested capital of 12.56.
| Return on Equity (ROE) | 20.80 |
| Return on Assets (ROA) | 11.59 |
| Return on Invested Capital (ROIC) | 12.56 |
| Return on Capital Employed (ROCE) | 16.72 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.90 |
Taxes
Over the trailing twelve months, Bioteque Corporation has paid 135.44M in income taxes, reflecting an effective tax rate of 20.08.
| Income Tax | 135.44M |
| Effective Tax Rate | 20.08 |
Stock Price Statistics
Bioteque Corporation's stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 116.28, while the 200-day moving average is 119.79.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 116.28 |
| 200-Day Moving Average | 119.79 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Bioteque Corporation generated 2.14B in revenue and converted that into 539.19M in net income, yielding earnings per share of 7.76. EBITDA reached 670.28M, while operating income came in at 670.28M.
| Revenue | 2.14B |
| Gross Profit | 936.94M |
| Operating Income | 670.28M |
| Pretax Income | 674.62M |
| Net Income | 539.19M |
| EBITDA | 670.28M |
| EBIT | 670.28M |
| Earnings Per Share (EPS) | 7.76 |
Balance Sheet
Bioteque Corporation holds 1.67B in cash and equivalents against 597.51M in total debt, resulting in a net debt position of -864.09M. Total book value stands at 2.66B, with working capital of 1.79B providing operational flexibility.
| Cash & Cash Equivalents | 1.67B |
| Total Debt | 597.51M |
| Net Debt | -864.09M |
| Equity (Book Value) | 2.66B |
| Book Value Per Share | 38.37 |
| Working Capital | 1.79B |
Cash Flow
Bioteque Corporation produced 664.20M in operating cash flow over the past twelve months. After subtracting -57.50M in capital expenditures, free cash flow totaled 606.70M - equivalent to 8.75 per share.
| Operating Cash Flow | 664.20M |
| Capital Expenditures | -57.50M |
| Free Cash Flow | 606.70M |
| FCF Per Share | 8.75 |
Margins
Bioteque Corporation operates with a gross margin of 43.88, reflecting its pricing power and cost economics. The operating margin of 31.39 and net profit margin of 25.25 provide insight into operational efficiency.
| Gross Margin | 43.88 |
| Operating Margin | 31.39 |
| Pretax Margin | 31.59 |
| Profit Margin | 25.25 |
| EBITDA Margin | 31.39 |
Dividends & Yields
The company's payout ratio of 64.26 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 5.00 |
| Dividend Yield | N/A |
| Payout Ratio | 64.26 |
| Shareholder Yield | 6.20 |
| FCF Yield | 8.62 |
Stock Splits
Bioteque Corporation's most recent stock split took place on September 2, 2015 with a 5:4 split ratio.
| Last Split Date | 9/2/2015 |
| Split Ratio | 5:4 |
Scores
Bioteque Corporation posts an Altman Z-Score of 6.75, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.75 |